Skip to content
Unrated Drug recall · FDA · Published May 11, 2016

Profarma Recalls 1% Clotrimazol Cream Due to CGMP Deviations

Profarma Distributors LLC recalls 79 boxes of 1% Clotrimazol cream due to Current Good Manufacturing Practice deviations. Check your lot and expiration date.

🇺🇸 FDA recall #D-1043-2016DrugProfarma ›
Take action

Contact the company

Recalling firmProfarma Distributors LLC4751 Poth Rd · Columbus, OH 43213-1331
✎ GovInfoNow plain-language explainer

What happened, in plain English

Profarma Distributors LLC is recalling 79 boxes (79 tubes) of 1% Clotrimazol cream because of Current Good Manufacturing Practice (CGMP) deviations. The product was distributed nationwide. No specific injury or hazard mechanism is described in the record, and no remedy has been provided. Read more at govinfonow.com/recall/42762-profarma-recalls-1-clotrimazol-cream-due-to-cgmp-deviations.

Source Summary by GovInfoNow · govinfonow.com/recall/42762-profarma-recalls-1-clotrimazol-cream-due-to-cgmp-deviations · Updated October 9, 2026 · FDA enforcement record: FDA #D-1043-2016

Cite this page

“Profarma Recalls 1% Clotrimazol Cream Due to CGMP Deviations.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42762-profarma-recalls-1-clotrimazol-cream-due-to-cgmp-deviations. Based on FDA recall #D-1043-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1043-2016%22&limit=1).

Why it’s dangerous

The recall is due to deviations from Current Good Manufacturing Practice (CGMP) standards. The record does not specify what these deviations were or how they could affect the safety or efficacy of the cream.

Who’s affected

Consumers who purchased 1% Clotrimazol cream from Profarma Distributors LLC between the manufacturing date and May 11, 2016. It is unclear who is most at risk as the specific nature of the CGMP deviation is not detailed.

How to tell if you have this one

Look for 1% Clotrimazol cream in a 30 mg tube with UPC 501318644335. Check if the lot number is GRU1390 and the expiration date is 08/17.

  • Brand
    Profarma
  • Category
    Drug
FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantity
D-1039-2016tabcin ACTIVE M.R. Capsules, 12-count box , UPC 7501008485057; Lot # 224TS; Exp. 02/1742 boxes (504 capsules)
D-1040-2016tabcin NOCHE; Capsules,12-count box, UPC 501008485033; Lot # X223FS; Exp. 11/1731 boxes ( 372 capsules)
D-1041-2016VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619; Lot # UPE187; Exp. 08/17163 boxes (978 tablets)
D-1042-2016VERMOX Tablets 500 mg, 1-count box, UPC 501109900596; Lot # UJE 040; Exp. 02/17254 boxes (254 tablets)
D-1043-20161% Clotrimazol cream, 30 mg tube, UPC 501318644335; Lot # GRU1390; Exp. 08/1779 boxes (79 tubes)

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 8 months after the firm started it.

1. Firm started the recall: May 11, 201612. FDA classified it Class II: Jun 17, 201623. Published in FDA’s Enforcement Report: Jun 29, 201634. FDA terminated the recall: Jan 24, 2017420162017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1043-2016 (May 11, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1043-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA